Search

Your search for "inm" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – Sycamore Entertainment Group Inc. (SEGI) Engages IBN for Corporate Communications Expertise

June 30, 2022

Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, today announced that it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. Through its wholly owned subsidiary SEGI.TV, Sycamore’s streaming experience is built on the pillars of equality, sustainability and community, offering movies and […]

Press Releases

IBN (InvestorBrandNetwork) Coverage Initiated for Sycamore Entertainment Group Inc.

LOS ANGELES, June 30, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Sycamore Entertainment Group Inc. (OTC: SEGI), a diversified entertainment company, today announces it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. Through wholly owned subsidiary SEGI.TV, Sycamore offers a streaming experience built on the pillars of […]

News Articles

Sycamore Entertainment Group Inc. (SEGI) Is ‘One to Watch’

June 29, 2022

Sycamore Entertainment Group Inc., through subsidiary SEGI.TV, offers a streaming experience built on the pillars of equality, sustainability and community SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others Sycamore has entered sponsorship agreements for multiple motorsports […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Proposed Underwritten Public Offering

June 21, 2022

Blue Hat (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China, has announced its intention to offer, in an underwritten public offering, its ordinary shares and pre-funded warrants to purchase ordinary shares. The pre-funded warrants shall be offered at the same price per share as […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Notified by NASDAQ, Regains Compliance

June 15, 2022

Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, and an operator of mobile games and augmented reality (“AR”) education curricula and products in China, has regained compliance with NASDAQ minimum bid price requirement. The company was notified by the Listing Qualifications Department of Nasdaq […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Results of Peer-Reviewed Study Published in International Journal

June 14, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has had its peer-reviewed scientific study published in the “International Journal of Molecular Sciences.” Titled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes,” the article reports on the study’s efforts to examine the biological activity of […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

June 9, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

June 7, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings

June 2, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced its entry into securities purchase agreements with a single health care-focused institutional investor for the issuance and sale of 4,079,256 of its common shares, each at a purchase price of $0.858 (or pre-funded warrant […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces 1-for-10 Reverse Stock Split

May 26, 2022

Blue Hat (NASDAQ: BHAT), a Cayman Islands company, today announced that it expects to implement a 1-for-10 reverse stock split on its ordinary shares effective Friday, May 27, 2022, with trading to begin on a split-adjusted basis at the market open on that day. Ordinary shares will continue trading on the Nasdaq Capital Market under […]

InvestorNewsBreaks

InvestorNewsBreaks – Ryoshis Vision (‘$RYOSHI’) Aims to Disrupt Entertainment and Technology Sectors

May 24, 2022

As the rise of a new crypto era begins, with mass adoption on the horizon from institutions and individuals, Ryoshis Vision (“$RYOSHI”) takes a revolutionary approach to create a burning protocol solution for the Shiba Inu ecosystem. With plans of turning into a decentralized autonomous organization (“DAO”), Ryoshis Vision is focused on disrupting the entertainment […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update

May 13, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced financial results for the third quarter ended March 31, 2022. “The third quarter of fiscal 2022 saw noticeable advancements across all of our programs, including commencing sales of the rare cannabinoids CBDV and CBT […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space

May 9, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of which are not yet available in commercial-size quantities, such as cannabidivarin – (“CBDV”) and tetrahydrocannabivarin – (“THCV”). “The acquisition of […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

May 5, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report

May 4, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. The piece details InMed Pharmaceuticals and its continued “transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement

April 28, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent […]

InvestorNewsBreaks

InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Identifying, Capturing High-Growth Technologies

April 21, 2022

Hollywall Entertainment (OTC: HWAL) is pushing the envelope, sparking conversations and innovating, particularly when it comes to technology and offering access to the internet. “Through its budding list of subsidiaries, the company has achieved a market cap of $73.53 million as of March 2022. For a company founded in 2009, its growth has been incredible […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is launching business-to-business sales of its rare cannabinoid cannabidivarin (“CBDV”). Through subsidiary BayMedica LLC, InMed will offer its product to wholesalers, suppliers and end-product manufacturers in the health and wellness sector. In addition, the company released a white paper […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences

April 19, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, will be involved in several conferences in April and May. Company management will be participating at the Benzinga Spring Cannabis Capital Conference, scheduled for April 20–21, 2022, in Miami Beach, Florida. InMed executives will be meeting virtually with institutions […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale

April 18, 2022

InMed Pharmaceuticals (NASDAQ: INM), a rare cannabinoid drug developer, is expanding its product manufacturing scale, thanks largely to the acquisition of consumer-focused rare cannabinoids manufacturer BayMedica last year. “InMed’s most-recent Q2 financial statement reported revenues of $0.3 million from commercial sales of cannabichromene (‘CBC’) to the health and wellness market following the BayMedica acquisition. Since […]

InvestorNewsBreaks

InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Empowering Small Communities to Pursue Concept Central to American Ideals

April 13, 2022

Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is focused on ensuring “digital equity” through access to the internet and its resources. “Hollywall president and CEO Darnell Sutton helped to pioneer the concept of ‘Fiber to the People’ as a way of empowering small communities, especially those in the South’s ‘Black Belt,’ to […]

News Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) Gaining Advantage on Processing Rare Cannabinoids with the Help of Subsidiary Bay Medica

April 12, 2022

There is an urgent need for large-scale biosynthetic processing that preserves the purity and consistency of cannabinoids Acquired by InMed in October 2021, Bay Medica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector InMed has two cannabinol formulations currently in development for ocular […]

News Articles

Hollywall Entertainment Inc. (HWAL) Leveraging Digital Technology for Continuous Growth

April 7, 2022

Hollywall Entertainment Inc. currently has a market cap of $73.53 million, attributed mainly to its leveraging of developing technologies The company, through HW Vision, a wholly-owned subsidiary, is pushing 5G and banking on its adoption over the coming years, projected to drive a 52% growth in the 5G services market by 2030 Hollywall is also […]

News Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

April 6, 2022

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its […]

News Articles

Hollywall Entertainment Inc. (HWAL) Dedicated to Extending Broadband, Fiber Services to Communications Tech ‘Deserts’

April 4, 2022

Hollywall Entertainment Inc. is a widely diversified technology and broadcasting company, with revenue streams derived from an extensive catalog of music, film, television, software and game library rights The company is dedicated to ensuring rural communities largely bereft of reliable communications technology embodied in broadband Internet are able to gain access to quality and affordable […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio

March 25, 2022

InMed Pharmaceuticals (NASDAQ: INM) President and CEO Eric A. Adams recently hosted a conference call and webcast in which he emphasized the company’s successful product diversification and strategic acquisition achievements. He expressed his optimism at the company’s expansion into the health and wellness sector as an ingredient supplier and the integration of BayMedica’s operations and […]

InvestorNewsBreaks

InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Creating One-of-a-Kind Digital System as NFTs are Set to Transform Music Industry

Hollywall Entertainment (OTC: HWAL), an innovative telecommunications and broadcasting company, understands the inherent value of non-fungible tokens (“NFTs”), which are poised to transform the music industry by facilitating equitable compensation for artists and enhancing the potential for remixes and collaborations. The company also understands that NFTs are becoming an integral part of how fans can […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management

March 17, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has announced changes in company leadership. According to the announcement, InMed chief financial officer Bruce Colwill is retiring, effective March 31, 2022; Colwill will serve as an advisor to the company through June 30, 2022, to ensure a smooth […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand

March 16, 2022

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, has dedicated itself to developing new therapeutic alternatives for the treatment of conditions with high unmet medical needs. The manufacturing process used by InMed and its recently acquired subsidiary BayMedica is unparalleled in the industry. “There […]

News Articles

Hollywall Entertainment Inc. (HWAL) Forays into Music NFTs as It Seeks to Offer Value to Musicians, Creatives, Shareholders

March 15, 2022

Hollywall formed a new R&D division to explore the use of cryptocurrency technologies, token omics, NFTs, and the blockchain The company is working on the HW Network digital delivery platform, a revolutionary digital distribution and verification system designed to maximize quality control, revenues for creators and copyright owners, and customer delivery NFTs have garnered a […]

News Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) Featured in Virtual Coverage of the 34th Annual Roth Conference

March 10, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is also a clinical-stage company developing a pipeline of rare […]

InvestorNewsBreaks

InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Drawing on Resources to Create Digital Equity

March 9, 2022

Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is employing its own methods to create digital equity. The company is drawing on resources that include its vast subsidiary holdings in the realms of telecommunications, infrastructure, technology, media, entertainment, and broadcasting to benefit rural, underserved communities. Hollywall aims to address the so-called digital divide […]

News Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) Updates Recent Product Diversification Efforts and Strategic Acquisitions Developments; Announces VP Of Sales & Marketing Appointment

In a recent update, InMed Pharmaceuticals president and CEO, Eric A. Adams, lauded the company’s progress and achievements so far, particularly with its product diversification and strategic acquisitions  Adams noted the company’s commitment to launching more products and executing more programs to continue growing its product portfolio  InMed also announced the appointment of Gerald (“Jerry”) […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference

March 8, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that its president and CEO Eric A. Adams will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022. Adams will host a fireside chat with Scoth Henry, managing director and head of pharmaceuticals […]

Press Releases

InMed to Present at the 34th Annual Roth Conference

Vancouver, BC, March 08, 2022 (GLOBE NEWSWIRE) — via InvestorWire — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces that Eric A. Adams, InMed’s President and Chief Executive Officer, will be presenting at the 34th Annual Roth Conference being held March 13-15, […]

InvestorNewsBreaks

InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) on Path to Redefining Entertainment Space, Stamping Leading Position in Other Sectors

March 3, 2022

Hollywall Entertainment (OTC: HWAL) has become one of the most promising enterprises in the telecommunication, infrastructure, media, technology, entertainment, and broadcasting space. “With a background of years of developing, producing and acquiring some of the world’s most prized entertainment properties and brands, this company is well on its way to redefining the entertainment space and […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica and the launch of cannabicitran (“CBT”) sales. “With the launch of business-to-business sales of CBT […]

News Articles

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

March 2, 2022

Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plant InMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022  Combination of complementary InMed and BayMedica business models key to increasing […]

News Articles

Hollywall Entertainment Inc. (HWAL) Works to Reduce Divide Between Digital Haves and Have-nots

February 24, 2022

Hollywall Entertainment Inc. is a technology and broadcasting company with varied interests in telecommunication, infrastructure, media, and entertainment Hollywall is actively working to help reduce the digital divide and empower rural, underserved communities — particularly across the South — through the extension of fiber optics and telecommunications services The company’s revenue streams range from its […]

News Articles

Esports Entertainment Group, Inc. (NASDAQ: GMBL) Featured in Virtual Coverage of the 34th Annual Roth Conference

February 23, 2022

Esports Entertainment Group (NASDAQ: GMBL) is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Their mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).